Doxorubicin Completed Phase 2 Trials for Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00931918Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients